Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Science Translational Medicine
Timothy P SheahanRalph S Baric

Abstract

Emerging viral infections are difficult to control because heterogeneous members periodically cycle in and out of humans and zoonotic hosts, complicating the development of specific antiviral therapies and vaccines. Coronaviruses (CoVs) have a proclivity to spread rapidly into new host species causing severe disease. Severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV) successively emerged, causing severe epidemic respiratory disease in immunologically naïve human populations throughout the globe. Broad-spectrum therapies capable of inhibiting CoV infections would address an immediate unmet medical need and could be invaluable in the treatment of emerging and endemic CoV infections. We show that a nucleotide prodrug, GS-5734, currently in clinical development for treatment of Ebola virus disease, can inhibit SARS-CoV and MERS-CoV replication in multiple in vitro systems, including primary human airway epithelial cell cultures with submicromolar IC50 values. GS-5734 was also effective against bat CoVs, prepandemic bat CoVs, and circulating contemporary human CoV in primary human lung cells, thus demonstrating broad-spectrum anti-CoV activity. In a mouse model of SARS-CoV pathogenes...Continue Reading

References

May 18, 2004·Biochemical and Biophysical Research Communications·Norio YamamotoNaoki Yamamoto
Dec 21, 2004·Biochemical and Biophysical Research Communications·Birgit MorgensternJindrich Cinatl
Sep 27, 2008·Journal of Virology·Eric F DonaldsonRalph S Baric
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kiira RatiaAndrew D Mesecar
Nov 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michelle M BeckerMark R Denison
Feb 27, 2009·Journal of Virology·Kristie D Ibarra, Julie K Pfeiffer
Jan 12, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hongjie YuYu Wang
Mar 27, 2012·Bioorganic & Medicinal Chemistry Letters·Aesop ChoChoung U Kim
Jul 19, 2012·The Journal of Infectious Diseases·Nguyet Minh NguyenCameron P Simmons
Apr 19, 2013·Scientific Reports·Darryl FalzaranoHeinz Feldmann
Sep 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Trevor ScobeyRalph S Baric
Oct 8, 2013·The Journal of Infection·Jasper F W ChanKwok-Yung Yuen
Mar 27, 2015·Clinical Microbiology Reviews·Jasper F W ChanKwok-Yung Yuen
Jun 27, 2015·PloS One·Vineet D MenacheryMartin T Ferris
Nov 10, 2015·Nature Medicine·Vineet D MenacheryRalph S Baric
Feb 13, 2016·Nature Reviews. Drug Discovery·Alimuddin ZumlaKwok-Yung Yuen
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Vineet D MenacheryRalph S Baric
Apr 14, 2016·Emerging Infectious Diseases·Anne LiljanderVictor Max Corman
May 23, 2016·Lancet·Michael JacobsEmma C Thomson
Jun 28, 2016·Nature Reviews. Microbiology·Emmie de WitVincent J Munster
Sep 30, 2016·The New England Journal of Medicine·Myoung-Don OhNam Joong Kim
Nov 29, 2016·Nature Microbiology·Adam S CockrellRalph S Baric

❮ Previous
Next ❯

Citations

Jul 7, 2018·Journal of Virology·Vineet D MenacheryRalph S Baric
Mar 9, 2019·Expert Opinion on Drug Discovery·Allison L Totura, Sina Bavari
Dec 28, 2017·Proceedings of the National Academy of Sciences of the United States of America·François FerronIsabelle Imbert
Aug 8, 2019·Chemistry, an Asian Journal·Erik De Clercq
Dec 6, 2019·Journal of Virology·Vineet D MenacheryRalph S Baric
Apr 3, 2020·Frontiers of Medicine·Min ZhouJieming Qu
Apr 8, 2020·Circulation Research·Akbarshakh Akhmerov, Eduardo Marban
Mar 29, 2020·Journal of Medical Virology·Cantong ZhangYong Dai
Apr 11, 2020·The New England Journal of Medicine·Jonathan GreinTimothy Flanigan
Mar 3, 2020·Journal of Medical Virology·Hongzhou LuYi-Wei Tang
Mar 11, 2020·Antimicrobial Agents and Chemotherapy·Miguel Angel Martinez
Apr 16, 2020·Pharmaceuticals·Jean Jacques Vanden Eynde
Apr 25, 2020·The New England Journal of Medicine·Rajesh T GandhiCarlos Del Rio
Mar 1, 2019·BMJ Global Health·Cassandra Kelly-CirinoMaria D Van Kerkhove
Apr 21, 2020·Journal of Biomolecular Structure & Dynamics·Subramanian BoopathiPonmalai Kolandaivel
May 5, 2020·European Heart Journal. Acute Cardiovascular Care·Leen Delang, Johan Neyts
Apr 23, 2020·Journal of the Pediatric Infectious Diseases Society·Kathleen ChiotosMari M Nakamura
Apr 8, 2020·Pharmacotherapy·Ashley BarlowMojdeh S Heavner
May 8, 2020·Drug Discoveries & Therapeutics·Ziyi LiGuowei Li
May 13, 2020·Journal of Cellular Physiology·Bahman YousefiMajid Eslami
May 14, 2020·The New England Journal of Medicine·Meghan E SiseEugene P Rhee
May 19, 2020·Reviews in Medical Virology·Danish RafiqM A Bazaz
May 6, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rami A BalloutAlan T Remaley
May 14, 2020·Journal of Biomolecular Structure & Dynamics·Mohammad Mahdi Nejadi BabadaeiMojtaba Falahati
May 8, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Luise HolzhauserAnn B Nguyen
May 21, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Keykavous ParangRakesh K Tiwari
May 28, 2020·The New England Journal of Medicine·Jason D GoldmanUNKNOWN GS-US-540-5773 Investigators
May 31, 2020·International Journal of Molecular Sciences·Isabella OrientiGiovanna Farruggia
Jun 9, 2020·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Alessandro FavilliSandro Gerli
Apr 17, 2020·Circulation·Nicholas S HendrenLeslie T Cooper
Jun 9, 2020·European Heart Journal·J M PericàsUNKNOWN Hospital Clínic Cardiovascular Infections Study Group
Apr 1, 2020·Journal of Medical Virology·Jahan S KhaliliYi Zhu
Jun 17, 2020·Pharmaceutical Patent Analyst·Hermann Am Mucke
Jun 2, 2020·Journal of Medical Virology·Xuefeng Liu, Abdul M Mondal
Jun 4, 2020·Pathogens·Sabari Nath Neerukonda, Upendra Katneni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.